Edwards Lifesciences Corp

NYSE:EW   10:01:06 AM EDT
98.42
-1.10 (-1.10%)
Other Pre-Announcement

Edwards Lifesciences Reports Second Quarter Results

Published: 07/28/2022 21:03 GMT
Edwards Lifesciences Corp (EW) - Edwards Lifesciences Reports Second Quarter Results.
Q2 Adjusted Earnings per Share $0.63.
Q2 Earnings per Share $0.65.
Q2 Sales $1.37 Billion.
Continues to Estimate That Global Tavr Opportunity Will Double to $10 Billion by 2028.
Expects Approximately 10 Percent Underlying Sales Growth in Second Half of Year.
Expects Full Year 2022 Sales of $5.35 to $5.55 Billion.
Expects Full Year Adjusted EPS Guidance at Bottom End of Its Original Guidance Range of $2.50 to $2.65.
For Q3 of 2022, Co Projects Total Sales to Be Between $1.30 and $1.37 Billion.
For Q3 of 2022, Company Projects Adjusted EPS of $0.58 to $0.66.
Q2 Earnings per Share View $0.64, Revenue View $1.40 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $2.56, Revenue View $5.71 Billion -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share View $0.65, Revenue View $1.44 Billion -- Refinitiv Ibes Data (analyst estimates).